1. Home
  2. MNOV vs CODA Comparison

MNOV vs CODA Comparison

Compare MNOV & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • CODA
  • Stock Information
  • Founded
  • MNOV 2000
  • CODA 1994
  • Country
  • MNOV United States
  • CODA United States
  • Employees
  • MNOV 13
  • CODA N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • MNOV Health Care
  • CODA Industrials
  • Exchange
  • MNOV Nasdaq
  • CODA Nasdaq
  • Market Cap
  • MNOV 91.7M
  • CODA 92.5M
  • IPO Year
  • MNOV 2005
  • CODA N/A
  • Fundamental
  • Price
  • MNOV $1.90
  • CODA $7.82
  • Analyst Decision
  • MNOV Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • MNOV 1
  • CODA 1
  • Target Price
  • MNOV $9.00
  • CODA $11.00
  • AVG Volume (30 Days)
  • MNOV 21.7K
  • CODA 34.0K
  • Earning Date
  • MNOV 02-18-2025
  • CODA 03-17-2025
  • Dividend Yield
  • MNOV N/A
  • CODA N/A
  • EPS Growth
  • MNOV N/A
  • CODA 14.29
  • EPS
  • MNOV N/A
  • CODA 0.32
  • Revenue
  • MNOV N/A
  • CODA $20,316,161.00
  • Revenue This Year
  • MNOV N/A
  • CODA $22.31
  • Revenue Next Year
  • MNOV N/A
  • CODA $12.02
  • P/E Ratio
  • MNOV N/A
  • CODA $24.53
  • Revenue Growth
  • MNOV N/A
  • CODA 4.98
  • 52 Week Low
  • MNOV $1.12
  • CODA $5.48
  • 52 Week High
  • MNOV $2.55
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • CODA 41.62
  • Support Level
  • MNOV $1.87
  • CODA $7.75
  • Resistance Level
  • MNOV $2.06
  • CODA $8.13
  • Average True Range (ATR)
  • MNOV 0.08
  • CODA 0.34
  • MACD
  • MNOV 0.00
  • CODA -0.05
  • Stochastic Oscillator
  • MNOV 47.48
  • CODA 7.22

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: